Bharat Biotech rubbishes criticism, says its vaccine is safe
New Delhi/Hyderabad: Hyderabad-based Bharat Biotech rejected Monday criticism over the grant of emergency use authorisation by India’s drug regulator to ...
Read moreDetails
New Delhi/Hyderabad: Hyderabad-based Bharat Biotech rejected Monday criticism over the grant of emergency use authorisation by India’s drug regulator to ...
Read moreDetailsNew Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreDetailsNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read moreDetailsMumbai: Dampening hopes of a COVID-19 vaccine by year-end, Serum Institute of India’s (SII) chief executive Adar Poonawalla has said ...
Read moreDetailsNew York: Reliance Jio Board Directors Isha Ambani and Akash Ambani are among the ‘emerging leaders’ from across the world. ...
Read moreDetailsPune: "More than enough" doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreDetails
Finally, the much-awaited biggest diplomatic breakthrough in the US-Israel war with Iran has been made with the US and Iran...
Read moreDetails
Kyiv saw a unique phenomenon recently when thousands of readers gathered at a literary festival defying air raids only to...
Read moreDetails
Aakar Patel A ‘New India’ has come upon us at such a rapid pace that it is important to...
Read moreDetails
By Dilip Cherian Retired Haryana-cadre IAS officer Ashok Khemka has secured a significant legal victory, with the Punjab and Haryana...
Read moreDetails
